Supported by:

















Bloodline - Hematology Education and News

Before and After Tranplantation: Treatment Strategies for Patients with Myelodysplastic Syndromes

 

This program was originally presented at the BMT Tandem Meetings, Thursday, February 16, 2006, in Honolulu, Hawaii. The program is intended for hematology and oncology specialists involved in BMT and those interested in treating myelodysplastic syndromes.

 

 



Modulation of the Clone: Altering the Course of The Myelodysplastic Syndrome
Dr. Lewis R. Silverman
Director, MDS and MPD Center
Mount Sinai School of Medicine
New York, New York

View Presentation


Bridge to Transplant in MDF/AML Patients
Vinod Parameswaran, MD
Avera Hematology and Transplant
Sioux Falls, South Dakota
View Presentation


Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with MDS and AML
Richard E. Champlin, MD
Department of Blood and Marrow Transplantation
MD Anderson Cancer Center
Houston, Texas

View Presentation
  Question and Answer Session
Chairman and Faculty Panel
View Presentation

  Download the program handout (1.5 MB PDF)



 

Supported by an unrestricted
educational grant from

 

Bloodline Updates

RSS / Subscribe
Advertisement